Online citations, reference lists, and bibliographies.
← Back to Search

Internalization Of PrP106–126 By The Formyl‐peptide‐receptor‐like‐1 In Glial Cells

L. Brandenburg, T. Koch, J. Sievers, R. Lucius
Published 2007 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Recent studies suggest that the formyl‐peptide‐receptor‐like‐1 (FPRL1) plays an essential role in inflammatory responses in the host defence mechanisms and neurodegenerative disorders. Furthermore, it may be involved in proinflammatory processes of prion diseases. However, little is known about the induction and regulation of PrP106–126‐induced receptor endocytosis. We have thus analysed whether PrP106–126 increases the activity of phospholipase D (PLD) via FPRL1, an enzyme involved in the regulation of the secretion, endocytosis and receptor signalling, in glial cells. PLD activity was determined using a transphosphatidylation assay and the internalization of PrP106–126, and FPRL1 was assessed by fluorescence microscopy and quantified by ELISA. We could show that PLD is activated by PrP106–126 both in astrocytes and microglia, and moreover that PrP106–126 is rapidly internalized via FPRL1 in astrocytes and microglia cells. The determination of receptor activity by extracellular signal‐regulated kinases 1/2 phosphorylation and cAMP level measurement verified the PrP106–126‐induced activation of FPRL1. FPRL1‐mediated PrP106–126 uptake was blocked by the receptor antagonist chenodeoxycholic acid. These studies indicate the involvement of FPRL1‐mediated cellular signalling in PrP106–126‐endocytosis and may allow the development of therapeutic agents interfering with prion uptake and/or PLD function, using either PLD or the FPRL1 as a possible pharmaceutical target.
This paper references
10.1038/362543A0
Neurotoxicity of a prion protein fragment
G. Forloni (1993)
10.1111/j.1471-4159.2005.03315.x
Functions and pathophysiological roles of phospholipase D in the brain
J. Klein (2005)
10.1111/j.1471-4159.2005.03081.x
The antimicrobial peptide rCRAMP is present in the central nervous system of the rat
Peter Bergman (2005)
10.1016/j.ijdevneu.2004.07.017
Role of cytokines and chemokines in prion infections of the central nervous system
M. Burwinkel (2004)
10.1074/JBC.270.50.29640
Human ADP-ribosylation Factor-activated Phosphatidylcholine-specific Phospholipase D Defines a New and Highly Conserved Gene Family (*)
S. Hammond (1995)
Role of cytokines and chemokines in prion
M. Baier (2004)
10.1083/JCB.139.5.1349
Multistep Navigation and the Combinatorial Control of Leukocyte Chemotaxis
E. F. Foxman (1997)
10.1091/MBC.E03-09-0673
Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis.
Guangwei Du (2004)
10.1016/S0165-0173(01)00150-3
Oxidative stress and the prion protein in transmissible spongiform encephalopathies
O. Milhavet (2002)
Neuroinflammation in Alzheimer’s
A. Williams (2002)
Fc gamma receptor-mediated activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonized particles.
D. Kusner (1999)
10.1523/JNEUROSCI.4303-03.2004
Neurons and Astrocytes Respond to Prion Infection by Inducing Microglia Recruitment
Mathieu Marella (2004)
10.1189/jlb.69.5.762
Assessment of neutrophil N‐formyl peptide receptors by using antibodies and fluorescent peptides
V. Loitto (2001)
10.4049/jimmunol.166.3.1448
Cutting Edge: The Neurotoxic Prion Peptide Fragment PrP106–126 Is a Chemotactic Agonist for the G Protein-Coupled Receptor Formyl Peptide Receptor-Like 11 2
Y. Le (2001)
Activation of the chemo
J. Van Damme (2000)
10.1523/JNEUROSCI.21-09-j0001.2001
Cocaine and Amphetamine Increase Extracellular Dopamine in the Nucleus Accumbens of Mice Lacking the Dopamine Transporter Gene
E. Carboni (2001)
10.1096/fj.05-4578fje
CpG‐containing oligodeoxynucleotide promotes microglial cell uptake of amyloid β 1–42 peptide by up‐regulating the expression of the G‐protein‐coupled receptor mFPR2
P. Iribarren (2005)
10.1016/j.neurobiolaging.2004.01.007
Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease
R. Nagele (2004)
Role for phospholipase D
Y. Shen (2001)
10.1074/JBC.M403012200
Phospholipase D1 Regulates Secretagogue-stimulated Insulin Release in Pancreatic β-Cells*
W. E. Hughes (2004)
10.1046/j.1471-4159.2003.02189.x
Phospholipase D2 modulates agonist‐induced µ‐opioid receptor desensitization and resensitization
T. Koch (2004)
10.1006/ABIO.1997.2299
Measurement of phospholipase D activity.
A. Morris (1997)
Phospholipase D 1 regulates secretagogue - stimulated insulin release in pancreatic beta - cells
E. HughesW. (2004)
10.1074/JBC.M206709200
ADP-ribosylation Factor-dependent Phospholipase D2 Activation Is Required for Agonist-induced μ-Opioid Receptor Endocytosis*
T. Koch (2003)
Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1.
Y. Le (2001)
Ral and phospholipase
M O.Poulter (2004)
A role for phospholipase D 1 in neurotransmitter release
Y. Humeau (2001)
10.1016/0092-8674(95)90525-1
Signal transduction and membrane traffic: The PITP/phosphoinositide connection
M. Liscovitch (1995)
10.1111/j.1471-4159.2004.02881.x
Increased expression of phospholipase D1 in the brains of scrapie‐infected mice
J. Jin (2005)
Characterization of chenodeoxycholic
M Z.Howard (2000)
10.1007/PL00000805
Signalling roles of mammalian phospholipase D1 and D2
S. Cockcroft (2001)
10.1023/A:1007028323666
Cellular uptake of the prion protein fragment PrP106-126 in vitro
Simon J. Mchattie (1999)
10.1523/JNEUROSCI.3155-04.2004
Ral and Phospholipase D2-Dependent Pathway for Constitutive Metabotropic Glutamate Receptor Endocytosis
M. Bhattacharya (2004)
10.4049/jimmunol.168.11.5682
Phospholipases D1 and D2 Regulate Different Phases of Exocytosis in Mast Cells
W. Choi (2002)
10.1016/S1388-1981(99)00093-1
Mammalian phospholipase D structure and regulation.
M. Frohman (1999)
RANTES activation of phospholipase D in Jurkat T cells: requirement of GTP-binding proteins ARF and RhoA.
K. Bacon (1998)
10.1083/JCB.85.3.890
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
K. D. Mccarthy (1980)
10.1016/S1388-1981(99)00098-0
Localization and possible functions of phospholipase D isozymes.
M. Liscovitch (1999)
10.1096/fj.02-0314fje
Activation of microglia by human neuromelanin is NF‐κB‐dependent and involves p38 mitogen‐activated protein kinase: implications for Parkinson's disease
H. Wilms (2003)
10.1074/JBC.M110274200
Mechanism of ADP Ribosylation Factor-stimulated Phosphatidylinositol 4,5-Bisphosphate Synthesis in HL60 Cells*
A. Skippen (2002)
10.1006/BBRC.2000.2770
Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines.
W. Shen (2000)
10.1002/glia.10146
Neuroinflammation in Alzheimer's disease and prion disease
P. Eikelenboom (2002)
10.1042/BJ3450401
Phospholipase D: molecular and cell biology of a novel gene family.
M. Liscovitch (2000)
The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1.
Y. Le (2001)
10.1523/JNEUROSCI.0653-05.2005
Uptake and Neuritic Transport of Scrapie Prion Protein Coincident with Infection of Neuronal Cells
A. C. Magalhães (2005)
10.1002/(SICI)1098-1136(200005)30:3<311::AID-GLIA10>3.0.CO;2-K
Upregulation of phospholipase D in astrocytes in response to transient forebrain ischemia
M. Lee (2000)
10.1074/jbc.M500122200
Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions*
L. Horonchik (2005)
10.1111/j.1471-4159.1976.tb06495.x
INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY
(1976)
10.1073/pnas.261358698
A role for phospholipase D1 in neurotransmitter release
Y. Humeau (2001)
10.1007/s000110050656
Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors
X. Chen (2000)
10.1128/MCB.21.2.595-602.2001
Role for Phospholipase D in Receptor-Mediated Endocytosis
Y. Shen (2001)
10.1016/S0014-5793(02)03405-1
Regulation of phospholipase D
J. Exton (1999)
10.1016/S1471-4906(02)02316-5
Formyl-peptide receptors revisited.
Y. Le (2002)
10.1046/j.1471-4159.1999.0732517.x
Ethanol Inhibits Astroglial Cell Proliferation by Disruption of Phospholipase D‐Mediated Signaling
K. Kötter (1999)
10.1016/0197-4580(94)93098-8
Neurotoxicity of the prion protein
J. Diedrich (1994)
10.1523/JNEUROSCI.21-02-j0003.2001
Amyloid β42 Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1
Y. Le (2001)
Microglia and the pathogenesis
P. Rezaie (2001)
10.1016/S0002-9440(10)61192-3
Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor.
E. Morel (2005)
10.1016/j.jneuroim.2004.08.010
The expression of RANTES and chemokine receptors in the brains of scrapie-infected mice
H. Lee (2005)
10.1074/JBC.M303789200
Phosphatidic Acid Regulates Systemic Inflammatory Responses by Modulating the Akt-Mammalian Target of Rapamycin-p70 S6 Kinase 1 Pathway*
Hyung-Kyu Lim (2003)
10.1038/sj.embor.embor768
The 37 kDa/67 kDa laminin receptor is required for PrPSc propagation in scrapie‐infected neuronal cells
C. Leucht (2003)
10.1111/j.1471-4159.2006.03736.x
Role of phospholipase D2 in the agonist‐induced and constitutive endocytosis of G‐protein coupled receptors
T. Koch (2006)
10.1016/S0165-0173(01)00042-X
Microglia and the pathogenesis of spongiform encephalopathies
P. Rezaie (2001)
10.1038/sj.embor.embor820
The 37 kDa/67 kDa laminin receptor is required for PrPSc propagation in scrapie‐infected neuronal cells
Christoph Leucht (2003)
10.1073/PNAS.95.23.13363
Nobel Lecture: Prions
S. Prusiner (1998)
10.4049/jimmunol.173.1.607
Identification of Peptides That Antagonize Formyl Peptide Receptor-Like 1-Mediated Signaling1
Y. Bae (2004)
10.1016/S0165-5728(00)00373-8
Expression of functional formyl peptide receptors by human astrocytoma cell lines
Y. Le (2000)
10.1007/978-3-642-16483-5_4540
[Phospholipase D].
T. Taki (1986)
10.1074/jbc.M410966200
Pathological Prion Protein Exposure Switches on Neuronal Mitogen-activated Protein Kinase Pathway Resulting in Microglia Recruitment*
Mathieu Marella (2005)
10.1084/JEM.189.2.395
A Seven-transmembrane, G Protein–coupled Receptor, FPRL1, Mediates the Chemotactic Activity of Serum Amyloid A for Human Phagocytic Cells
S. B. Su (1999)
10.1074/jbc.274.1.494
Molecular Analysis of Mammalian Phospholipase D2*
T. Sung (1999)



This paper is referenced by
10.1016/j.molimm.2010.03.012
Antimicrobial peptide rCRAMP induced glial cell activation through P2Y receptor signalling pathways.
L. Brandenburg (2010)
10.1016/j.neuroscience.2008.07.042
Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells
L. Brandenburg (2008)
10.1016/j.tips.2010.04.001
Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia–reperfusion injury?
F. Gavins (2010)
10.1007/s11064-010-0301-5
Expression and Signaling of Formyl-Peptide Receptors in the Brain
F. Cattaneo (2010)
10.1186/1742-2094-8-11
The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis
B. J. Braun (2010)
10.1016/j.intimp.2013.10.028
Aspirin-triggered lipoxin A4 attenuates lipopolysaccharide induced inflammatory response in primary astrocytes.
C. Yao (2014)
10.1016/j.bmc.2015.03.062
Non-peptide ligand binding to the formyl peptide receptor FPR2--A comparison to peptide ligand binding modes.
Tomasz M. Stepniewski (2015)
10.1074/jbc.M109.007526
CD36 Is a Novel Serum Amyloid A (SAA) Receptor Mediating SAA Binding and SAA-induced Signaling in Human and Rodent Cells*
I. Baranova (2010)
10.1177/039463200902200405
Suppression of Map Kinases Inhibits Microglial Activation and Attenuates Neuronal Cell Death Induced by α-Synuclein Protofibrils
H. Wilms (2009)
10.1007/s12031-017-0924-y
Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination
Kai Bihler (2017)
10.1111/imm.12324
Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis
Sandra Oldekamp (2014)
10.1016/j.aanat.2009.06.003
Internalization and signal transduction of PrP(106-126) in neuronal cells.
L. Brandenburg (2009)
10.1186/s12974-020-02006-w
The formyl peptide receptor agonist Ac2-26 alleviates neuroinflammation in a mouse model of pneumococcal meningitis
Marvin Rüger (2020)
10.1371/journal.pone.0075543
Spinal Actions of Lipoxin A4 and 17(R)-Resolvin D1 Attenuate Inflammation-Induced Mechanical Hypersensitivity and Spinal TNF Release
S. Abdelmoaty (2013)
10.1371/journal.pone.0100522
Deficiency of Formyl Peptide Receptor 1 and 2 Is Associated with Increased Inflammation and Enhanced Liver Injury after LPS-Stimulation
A. Giebeler (2014)
10.14288/1.0167452
Islet amyloid polypeptide aggregation is a local trigger for pancreatic islet inflammation
C. Westwell-Roper (2014)
10.1186/1742-2094-9-278
Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines
S. Hu (2011)
10.1111/j.1471-4159.2010.06637.x
Functional and physical interactions between formyl‐peptide‐receptors and scavenger receptor MARCO and their involvement in amyloid beta 1–42‐induced signal transduction in glial cells
L. Brandenburg (2010)
10.3390/ijms19041211
Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury
J. Ansari (2018)
10.1111/j.1471-4159.2010.06934.x
Interactions of the prion peptide (PrP 106–126) with brain capillary endothelial cells: coordinated cell killing and remodeling of intercellular junctions
I. Cooper (2011)
Contribution of Astrocytes to CNS Immunity: Roles of Pattern Recognition Receptors (PRRs)
Nilufer Esen (2011)
10.3390/ijms20143426
Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors
Stacey A Krepel (2019)
10.3390/ijms14047193
Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists
F. Cattaneo (2013)
10.1186/1750-1326-7-55
Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE) - and amyloid beta 1-42-induced signal transduction in glial cells
A. Slowik (2012)
10.3390/membranes4030302
Role of Phospholipase D in G-Protein Coupled Receptor Function
L. Brandenburg (2014)
10.1186/s12974-020-01816-2
Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease
Nicole Schroeder (2020)
10.1007/s12250-010-3143-z
PrP 106-126 Altered PrP mRNA gene expression in mouse microglia BV-2 Cells
Y. Bai (2010)
10.1152/ajpcell.00380.2008
Lipoxin A4 inhibits IL-1beta-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells.
Y. Decker (2009)
Semantic Scholar Logo Some data provided by SemanticScholar